BioLizard NV
For years, the life sciences industry has been experiencing a surge in data generation, sparking a race to uncover valuable insights. When data analytics is executed effectively, this wealth of information offers vast potential for medical advancements. However, such data-driven development also presents significant challenges in extracting meaningful information.
BioLizard bridges the gap between biological research and computational science, helping researchers make sense of their complex datasets. As a global leader in data science, BioLizard employs advanced bioinformatics, and machine learning to create custom solutions tailored to the industry‘s needs.
About BioLizard NV:
| Field of Activity | Data analytics and data management consulting as well as software engineering and bioinformatics. |
| Founders and Financing | Wim Van Criekinge, Gerben Menschaert, and Jan Van den Berghe, privately financed. |
| Partners | BioLizard cooperates with leading stakeholders in the industry such as Illumina, Pierre Fabre Oncology, Tercen, Flanders.Bio, and Abnomx. |
| Services | BioLizard‘s solutions accelerate biomarker discovery, help identify new drug targets and mechanisms of action (MOA) and offer a deeper understanding at the molecular level. At the core of BioLizard‘s offerings is Bio|Verse, an innovative software platform that allows researchers to interact with, explore, and compare their scientific and biomedical data by handling multi-omics datasets – a computationally intensive task. Bio|Verse helps maximize integration, curation, and transferability across the customer‘s projects. With Bio|Verse, BioLizard goes beyond services by translating complex data into actionable insights that accelerate R&D efforts, addressing the unique challenges in life sciences. |
| Unique Selling Point | BioLizard accommodates a uniquely qualifi ed team of 50+ experts, the “Lizards,” who bring together their software assets, expertise and abilities, in data management, bioinformatics, and AI-driven data analytics. At the same time, their background in biology and computer sciences enables them to apply specialist understanding for each client’s data and needs, providing insights and tools that maximize return on investment. Customer intimacy is in their DNA. |
| Date of Incorporation/ Number of Employees |
*2018 / 50 |
Contact:
| Address | BioLizard nv Foreestelaan 88 9000 Ghent, Belgium |
| contact@lizard.bio | |
| Web Address | https://lizard.bio/ |
| Social Media |
ARTIKEL ZU DIESEN SCHLAGWORTEN
- "Echte Innovation heißt: Spürbar bessere medizinische Versorgung"
- GFT Technologies: „Wir sehen ein großes Potenzial zur Effizienzsteigerung“
- Internal Audit: Schlüssel zum Erfolg im IPO-Prozess
- „Das Problem des ‚Undruggable‘ war bisher ein Problem des ‚Invisible‘, das wir gelöst haben.“
- Out now! Special „Corporate Finance Recht 2024“
- Molecular Health und Integrated DNA Technologies vereinbaren kommerzielle Partnerschaft
- 23 Millionen Euro für Smart Reporting
- Can biopharma’s drug-focused R&D strategy remain profitable?
- Vorschau auf die analytica 2024
- Wie künstliche Intelligenz die Gesundheitsindustrie verändert
- Hey, it’s a Match!
- Navigating the AI Revolution - A Venture Capitalist‘s Journey in Transforming Healthcare
- Heading the digital transformation in the life sciences industry
- How to achieve investment readiness in the food industry?
- The potential of AI in drug discovery
- BioLizard startet neue KI-unterstützte Plattform „BioVerse“
- W&I-Policen zunehmend für kleinere Deals zugänglich
- Was Künstliche Intelligenz im M&A-Geschäft bringt
- BioNTech schließt Übernahme von InstaDeep ab
- KI für Gewebeproben: AIgnostics erhält Seed-Finanzierung